Can NK cells maintain the remission of MS?

Natural killer cells from multiple sclerosis patients in remission have properties resembling those of NK type 2 cells, which can favour functional deviation of T cells toward Th2 and prohibit autoimmune effector T cells.

Tudor Toma(ttoma@mail.dntis.ro)
Mar 15, 2001

Multiple sclerosis (MS) is a Th1-mediated autoimmune disease characterised by relapses followed by clinically stable remissions. A new hypothesis suggests that regulatory immune cells may play an active part not only in relapses but also in maintaining the remission of MS. In the Journal of Clinical Investigation (published online ahead of print), Takahashi et al provide the first evidence of a role for natural killer (NK) cells in the remission of MS (J Clin Invest 2001, 107:R23-R29).

Kazuya Takahashi and colleagues examined NK cells in the peripheral blood of 22 patients with MS and found that during remissions these cells were characterized by an elevation of IL-5 mRNA and a decreased expression of IL-12Rβ2 mRNA. Moreover, the NK cells produced larger amounts of IL- 5 than controls after non-specific stimulation.

These features resemble those of NK type 2 cells, which can favour functional deviation of T cells toward...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?